Standard BioTools

Company Snapshot

Founded: 1999
Entity Type: Public
Employees: 818
Region: Americas
Revenue: $174.4 Millions
Revenue Year: 2024
Headquarter: California, U.S.
Corporate Address: 2 Tower Place, Suite 2000 South San Francisco, California 94080 U.S. Tel. +1-650-266-6000 www.standardbio.com

Company Overview

Standard BioTools provides microfluidic-based chips and instrumentation systems. The company provides the BioMark System, which is used for genetic analysis, and the Topaz system, which is used for the crystallization of protein. It is headquartered in San Francisco, California, and promotes its microfluidic systems to pharmaceutical and biotechnological companies and academic and research institutions worldwide. The company has distributors and sales offices in Europe, Australia, and Asia-Pacific.

For gene expression and single-nucleotide polymorphism type (SNP Type) assays, our offerings comprise assay design and customized content delivery systems. These products give clients more flexible use of IFCs with validated assays for their desired targets at a lower cost than other available chemistries.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Standard BioTools In Reports

Global Biochip Markets: Microarrays and Lab-on-a-Chip

According to our Research Report the biochips market report includes global revenue ($ Million) for base year data of 2023 and estimated data for the forecast period 2024 through 2029.

Proteomics: Technologies and Global Markets

According to BCC Research proteomics market includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.

Single-Cell Genomics and Proteomics: Emerging Technologies and Markets

BCC Research Report: Dive into Single-Cell Genomics and Proteomics Market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2029.

Company's Business Segments

  • Proteomics : This segment includes Instruments, Consumables, Reagents, Software, Services for all Technologies used in the identification of Proteins. Proteins perform a Vast Array of Functions within Living Organisms, including Catalyzing Metabolic Reactions, Replicating DNA, Signaling Response to Stimuli and Transporting Molecules from one location to another.
  • Genomics : Genomics is broadly defined as Instruments, Consumables, Reagents, Software, Services for all Technologies used in the Identification of Genes (DNA, RNA). Analysis of Variations in Genomes, Genes, Gene Activity in and between Organisms can provide insights into their Health and Functioning.

Applications/End User Industries

  • instruments
  • Consumables
  • Reagents
  • Proteomics
  • Genomics
  • DNA
  • Immunohistochemistry
  • Genotyping
  • mRNAs
  • Cytometry